I personally think it is a little bit early for them to be talking about upscaling and large-scale production this early into clinical trialing?
Maybe I am mistaken, but do other biotechs look to produce large quantities this early on in the game?
Ann: Positive Sinusitis Patient Update - Special Access Scheme, page-84
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 31.0¢ | $17.20K | 54.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5861 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 38346 | 4 |
View Market Depth
| Last trade - 11.00am 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |